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Identifying plant extracts as sources of antimalarial compounds needs to be addressed as numerous 
studies screen extracts without the means of eliminating extracts that are merely cytotoxic. Fifty-nine 
organic solvent extracts from South African plants were screened for antiplasmodial activity using the 
[3H]-hypoxanthine incorporation assay against the chloroquine-resistant Plasmodium falciparum.  
Variable antiplasmodial activity and toxicity was observed. Extracts form Combretum erythrophyllum 
and Crinum bulbispermum, had IC50 values  1 µg/ml with the ethyl acetate extracts of C. 
bulbispermum roots and bulbs having values comparable to chloroquine (0.04 µg/ml). Nine extracts had 
toxicity indexes  100. Lycorine, isolated from C. bulbispermum was as active as chloroquine (IC50 of 
0.03 µg/ml) and had a favourable security index. 
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It is estimated that 80% of people living in developing 
countries are almost completely dependent on traditional 
medicinal practices for their primary health care needs. 
Higher plants are also known to be the main source of 
drug therapy in traditional medicine. While the scientific 
world races to find a new cure for the mosquito-borne 
disease, a child dies every 3 to 5 minutes of malaria, 
attributing to the 300 to 500 million clinical cases each 
year and a staggering 1.5 to 2.7 million deaths (Breman, 
2001). Malaria is a protozoal disease caused by four 
Plasmodium species. Plasmodium falciparum is one of 
the agents of malaria. Resistance to the most common 
antimalarial drugs has spread to almost every part of the 
world contributing to the urgency for the development of 
new compounds for malaria therapy (Winstanley, 2000). 
Efforts are now being directed towards obtaining drugs 
with different structural features, along with new strate-
gies in malaria control and the recognition and validation 
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A large number of reports on the in vitro antiplasmodial 
activities of plant extracts without reference to toxicity 
have been published lately (Clarkson et al., 2004; 
Saxena et al., 2003). In these circumstances it is not 
always clear if the reported activity could be related to a 
general cytotoxicity. A publication by van Zyl and Viljoen 
(2002) reported on both the antiplasmodial activity and 
toxicity of Aloe species; while Atindehou et al. (2004) and 
Prozesky et al. (2001) reported the antiplasmodial activity 
of a substantial list of plant extracts, but the toxicity of 
only a selected few of the list of extracts. 
In this study fifty-nine different extracts from six plant 
species selected from literature were screened for anti-
plasmodial activity as well as toxicity. This was done to 
confirm antiplasmodial activity as opposed to general 




MATERIALS AND METHODS 
 
Selection and collection of plant material  
 
Six South African plants were selected based on reported antiplas-
modial activity in  related  species  (Clarkson et al., 2004)  and  their  
 




Table 1.  Medicinal plants used in this study. 
 








To treat colds, rheumatism, earache, septic sores, 
haemorrhoids and rheumatic fever. Also used as a rat 
poison (Watt and Breyer-Brandwijk, 1962) 




Antimicrobial concoctions (Saxena  et al., 1994), 
gastritis, stomach cancer and arteriosclerosis (Lee et 
al., 2004) 
Combretaceae C. erythrophyllum (Burch.) Sond. 
Leaves 
Stems 
Malaria (Benoit-Vical et al., 1999), bilharziasis, 
hookworm, antimicrobial infections, fever, headaches,  
(Masoko et al., 2007) 




Treat infectious diseases and the recurrent fever typical 
of malaria (El Tahir et al., 1999) 
Liliaceae 
A. greatheadii Schonl. 
var davjana (Schonl.) 
Glen and Hardy 
Leaves 
Used for antibacterial, antifungal, antiviral, antimalarial 
properties. Against trypanosomiasis and for cathartic 
effects (van Zyl and Viljoen, 2002). 




Used for antimalarial activity (Sanon et al., 2003), 
respiratory and abdominal disorders, fevers (Grosvenor 




availability (Table 1). The plants were collected from the Botanical 
Garden of the North-West University (Potchefstroom Campus) and 
identified by the curator of the garden, Mr Peter Mortimer. Voucher 
specimens are kept at the A.P. Goossens Herbarium (PUC), North-
West University, Potchefstroom. 
 
 
Preparation of extracts 
 
Plant samples were separated into different morphological parts. 
Leaves, stems and seeds were dried at room temperature for five 
days, while roots and bulbs were frozen. Dried plant parts were 
grounded to a coarse powder, while the frozen parts were cut into 
smaller pieces. Extracts were prepared by sequential Soxhlet 
extraction of 5-20 g of plant material with petroleum ether, 
dichloromethane, ethyl acetate and ethanol. Solvents were 
removed using rotary vacuum evaporation. 
 
 
In vitro antiplasmodial screening 
 
A chloroquine-resistant strain (FCR-3) of P. falciparum was 
continuously cultured according to the method of Trager and 
Jensen (1976) which entailed the daily replacement of culture 
medium and the addition of washed erythrocytes every second day 
when parasites were in the trophozoite-schizont stage. Washed 
erythrocytes were obtained by centrifuging whole blood at 400 x g 
for 5 minutes and then removing the plasma portion and leukocyte 
buffy coat. The [3H]-hypoxanthine incorporation assay of Desjardins 
et al. (1979) was used to determine antiplasmodial activity on 
synchronised ring stage parasites (Lambros and Vandenberg, 
1979).  Synchronisation of the ring stage was achieved by adding 
sorbitol to the medium every second day when the parasites were 
in the ring stage. The parasite culture was adjusted to 0.5% 
parasiteamia and 1% heamatocrit. Parasiteamia was determined 
with Giemsa staining. 96-Well microplates were prepared by filling 
each well with standardised parasite culture and adding solubilised 
plant extracts in various dilutions. Plant extracts were reconstituted 
in DMSO and then diluted to render solutions with a maximum con-
centration of 1% DMSO. A negative control (uninfected erythro-
cytes) and an untreated parasite control were included. After 
incubation of 24 hours at 37°C under anaerobic conditions [3H]-
hypoxanthine was added to all wells and the plates were again 
incubated for 24 hours at 37°C under anaerobic conditions. Incor-
poration of [3H]-hypoxanthine into DNA was measured by liquid 
scintillation counting. The results were expressed as a percentage 
of parasite growth and the IC50 values of the plant extracts and 
standard antimalarials were calculated from log sigmoid dose 
response curves by the Enzfitter® programme. Chloroquine diphos-
phate and quinine sulphate were used as reference compounds. All 





To determine the toxicity of the plant extracts on human kidney 
epithelial (Graham 293) cells, the MTT [3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyl tetrazolium bromide] toxicity assay was used 
(Mosmann, 1983). Graham cells were cultured in Ham F10 medium 
containing heat inactivated foetal calf serum and 0.1% gentamicin. 
The medium was replaced every second day, trypsinised once 
weekly and then allowed to reach confluency. Dilutions and 
appropriate DMSO controls were prepared and plated out in 
quadruplicate in 96-well plates to a cell suspension of 0.5 million 
cells/ml. A concentration of 1% DMSO (v/v) was not toxic to the 
epithelial cells. Each plate contained an untreated cell control and a 
blank control (containing no cells).  Prepared plates were incubated 
at 37°C for 44 hours in a 5% CO2 environment.  After incubation 
sterile MTT solution was added to each well and plates incubated 
for another 4 hours. Absorbance of the formed formazan product 
was measured at a test wavelength of 540 nm and a reference 
wavelength of 690 nm. Results were expressed as percentage 
cellular viability of the extract and cell-free controls. All assays were 
done in quadruplicate. Security indexes (Benoit-Vical et al., 1999) 
were calculated as an indication of the toxicity of the prepared plant 
extracts in relation to its antimalarial activity. 
 
Security  index  =  Cytotoxicity  (IC50 µg/ml)/Antiplasmodial  






Isolation of lycorine 
 
Isolation of pure lycorine from C. bulbispermum was achieved by 
column chromatography on silica gel (size 0.063-0.2 mm, 
Macherey-Nagel) with petroleum ether-dichloromethane-ethyl 
acetate (4:8:1) as mobile phase. 13C and 1H nuclear magnetic 
resonance (NMR) spectra were recorded on a Varian Gemini 300 in 
DMSO-d6. 13C spectra were recorded at a frequency of 75,462 MHz 
and 1H spectra at a frequency of 300,075 MHz. All chemical shifts 
are reported in parts per million (ppm) relative to tetramethylsilane 





Results obtained from the [3H]-hypoxanthine incorpo-
ration assay, the MTT-assay and the calculated security 
indexes of the tested plant extracts and reference com-
pounds (chloroquine and quinine) are shown in Table 2. 
Eleven extracts had IC50 values  1 µg/ml with two 
extracts comparable to chloroquine (0.04 µg/ml). Nine 
extracts had toxicity indexes  100. The extracts of C. 
bulbispermum were the most promising candidates for 
further study. 
The comparison of spectral data with that found in the 
literature to confirm the structure of lycorine (Figure 1) is 





Most extracts inhibited parasite proliferation by more than 
50% at a concentration of 50 µg/ml. Only nine of the fifty-
nine extracts had security indexes of greater than 100 
and were considered to have antiplasmodial activity as 
opposed to general cytotoxicity (highlighted in Table 2). 
The most promising extract was the ethyl acetate bulb 
extract of C. bulbispermum with an IC50 value of 0.08 µg/ 
ml and a security index of 2203.13. 
A. greatheadii showed very little antiplasmodial activity 
and appeared to be toxic against the human kidney 
epithelial cell line. The weak antiplasmodial activity of 
Aloe species in general is confirmed by van Zyl and 
Viljoen (2002), as well as Clarkson et al. (2004) with IC50 
values mostly being greater than10 µg/ml.   
M. heterophylla extracts showed moderate but variable 
antiplasmodial activity, with IC50 values ranging between 
1.20 and 89.47 µg/ml, with the best activity being dis-
played by the dichloromethane stem extract (IC50 value: 
1.20 ± 0.93 µg/ml). The high security index (224.82) of 
the ethanol extract of the seeds of this species indicated 
that it possessed more antiprotozoal activity as opposed 
to being cytotoxic.  Extracts of M senegalensis and M 
undata were also reported by Clarkson et al. (2004) to 
have little antiplasmodial activity with IC50 values greater 
than 15 µg/ml against the chloroquine-sensitive D10 
strain. Atindehou et al. (2004) also reported IC50 values of 
greater than 5 µg/ml for M senegalensis; while Prozesky 
et al. (2001)  reported  values  of   greater  than  50 µg/ml  




against the chloroquine-resistant PfUP1 strain. 
Both R. pyroides and P. gardeniifolia showed moderate 
to good activity in the tritiated hypoxanthine incorporation 
assay, but the extracts were considered to be more cyto-
toxic rather than antiplasmodial. Sanon et al. (2003) and 
Weninger et al. (2004) also reported weak antiplasmodial 
activity for Pavetta species. 
C. erythrophyllum extracts displayed potent antiplas-
modial activity (IC50 values ranging from 0.70 and 10.68 
µg/ml), especially the leaves with an IC50 value of 0.87 
µg/ml. Clarkson et al. (2004) reported weaker activity for 
the twigs of C. zeyheri (IC50 value of 15 µg/ml) and 
Atindehou et al. (2004) also reported IC50 values of more 
than 5 µg/ml for C. molle, C. racemosum and C. 
smeathnannii extracts.  
C. bulbispermum root and bulb extracts showed 
remarkably potent antiplasmodial activity with varying 
toxicity, although Clarkson et al. (2004) reported poor 
activity for C. macowanii bulb extracts. The ethyl acetate 
extract of C. bulbispermum bulbs had the best profile with 
an IC50 value of 0.08 µg/ml for antiplasmodial activity and 
a security index of 2203. Due to these promising proper-
ties, further purification of this extract was performed. On 
comparison of the physical data (Table 3) to that found in 
the literature (Likhitwitayawuid et al.,1993), the com-
pound was identified as lycorine (Figure 1, Table 3), 
which has been isolated from C. amabile and Brunsvigia 
radulosa (Campbell et al., 2000). Lycorine was identified 
as a potent antiplasmodial compound with an IC50 value 
of 0.03 µg/ml against the chloroquine-resistant strain 
(FCR-3) of P. falciparum, which is comparable to the 
activity of the crude extract and chloroquine. 
Likhitwitaywuid et al. (1993) reported an IC50 value of 0.3 
µg/ml for lycorine isolated from C. amabile against the 
chloroquine-resistant strain (W-2). Campbell et al. (2000) 
reported IC50 values of 0.6 and 0.7 µg/ml for lycorine 
isolated from B. radulosa against the strains D-10 and 
FAC8, respectively. Reports on the cytotoxicity of lycorine 
vary considerably and this study reports an IC50 value of 
445.47 µg/ml for lycorine against human kidney epithelial 
cells. Likhitwitaywuid et al. (1993) reported IC50 values for 
ranging from 0.3 to 1.6 µg/ml against a series of human 
cancer cells.  The anti-cancer activity of lycorine was also 
reported by Li et al. (2007) as an effect due to the 
apoptosis inducing effect of lycorine. Lycorine further has 
been found to inhibit protein synthesis (Jimenenz et al., 
1976). 
Although different species and extracts of the plants 
investigated in this study have been reported on in 
literature, the findings of this study seem consistent with 
the fact that when the results of an antiplasmodial 
screening are combined with toxicity studies, very few 
plants can be considered as good candidates for further 
investigation. Bearing in mind that natural phytomole- 
cules such as quinine and artemisinin have acted as 
templates for the development of antiplasmodial agents, 
it is encouraging to find that the antiplasmodial activity of 
 




Table 2. IC50 values for antiplasmodial and toxicity assays and calculated security indexes for South 




activity IC50 (µg/ml) ± 
S.D. (n = 3) 
Toxicity IC50 




A. greatheadii var davyana    
leaves:    
petroleum ether 4.90 ± 2.98 4.7 ± 0.78 0.97 
dichloromethane 32.45 ± 6.58 392.96 ± 83.89 12.11 
ethyl acetate 43.18 ± 21.84 144.51 ± 60.37 3.35 
ethanol 27.04 ± 12.89 94.30 ± 38.90 3.49 
C. erythrophyllum    
leaves:     
petroleum ether 1.18 ± 0.49 66.04 ± 7.58 55.97 
dichloromethane 0.70 ± 0.25 42.78 ± 7.24 61.11 
ethyl acetate 1.04 ± 0.36 32.92 ± 2.65 31.65 
ethanol 0.87 ± 0.28 925.72 ± 20.38 1064.05 
stems:     
petroleum ether 1.47 ± 0.38 2.74 ± 0.23 1.86 
dichloromethane 0.70 ± 0.21 70.51 ± 6.59 100.73 
ethyl acetate 10.68 ± 0.03 20.85 ± 7.74 1.95 
ethanol 4.41 ± 1.65 66.97 ± 4.38 15.19 
C.  bulbispermum    
leaves:     
petroleum ether 0.89 ± 0.19 45.17 ± 6.67 50.75 
dichloromethane 1.96 ± 1.10 11.08 ± 1.96 5.65 
ethyl acetate 15.16 ± 3.21 20.56 ± 1.72 1.35 
ethanol 62.29 ± 16.86 11.69 ± 1.73 0.19 
roots:     
petroleum ether 3.54 ± 1.48 16.08 ± 9.99 4.54 
dichloromethane 1.03 ± 0.08 2.36 ± 0.65 2.29 
ethyl acetate 0.02 ± 0.01 9.60 ± 5.02 480.00 
ethanol 18.23 ± 0.56 171.08 ± 56.73 9.38 
bulbs:     
petroleum ether 0.40 ± 0.09 177.57 ± 45.57 443.93 
dichloromethane 0.38 ± 0.03 9.71 ± 8.94 25.55 
ethyl acetate 0.08 ± 0.01 176.25 ± 12.58 2203.13 
ethanol 0.32 ± 0.13 8.71 ± 0.31 27.22 
M. heterophylla    
leaves:     
petroleum ether 12.58 ± 4.45 36.67 ± 3.61 2.91 
dichloromethane 2.10 ± 0.57 7.37 ± 1.57 3.51 
ethyl acetate 3.84 ± 0.96 26.17 ± 0.11 6.82 
ethanol 89.47 ± 46.65 64.41 ± 11.52 0.72 
seeds:     
petroleum ether 23.09 ± 7.58 5.44 ± 0.29 0.23 
dichloromethane 20.07 ± 2.42 90.19 ± 41.71 4.49 
ethyl acetate 3.00 ± 0.46 47.01 ± 4.37 15.72 
ethanol 27.84 ± 6.50 6259.30 ± 45.57 224.82 
stems:     
petroleum ether 6.36 ± 0.32 50.61 ± 5.18 7.96 
dichloromethane 1.20 ± 0.93 34.21 ± 5.25 28.51 
 




Table 2. contd. 
 
ethyl acetate 1.36 ± 0.54 58.84 ± 2.41 43.26 
ethanol 10.56 ± 0.53 230.82 ± 5.40 21.86 
P. gardeniifolia    
leaves:     
petroleum ether 5.50 ± 0.58 25.93 ± 2.37 4.71 
dichloromethane 12.91 ± 1.24 238.95 ± 8.14 18.51 
ethyl acetate 7.28 ± 4.14 236.86 ± 143.28 32.54 
ethanol 21.15 ± 1.35 729.71 ± 245.39 34.50 
seeds:     
petroleum ether 3.39 ± 1.43 225.47 ± 37.37 66.51 
dichloromethane 1.30 ± 0.49 153.43 ± 61.08 118.02 
ethyl acetate 35.42 ± 14.64 495.94 ± 161.32 14.00 
ethanol 4.30 ± 0.61 384.31 ± 171.10 89.37 
stems:     
petroleum ether 1.83 ± 0.20 50.75 ± 14.73 27.73 
dichloromethane 1.47 ± 0.39 1065.90 ± 1610.6 725.10 
ethyl acetate 3.32 ± 0.54 87.22 ± 8.26 26.27 
ethanol 19.92 ± 0.36 540.15 ± 219.48 27.12 
R. pyroides    
leaves:    
petroleum ether 1.68 ± 0.11 50.32 ± 4.17 29.95 
dichloromethane 1.00 ± 0.41 7.17 ± 0.93 7.17 
ethyl acetate 1.32 ± 0.31 84.11 ± 1.85 63.72 
ethanol 9.30 ± 1.84 942.53 ± 800.00 101.34 
seeds:     
petroleum ether 9.67 ± 0.43 82.85 ± 17.13 8.57 
dichloromethane 1.60 ± 0.95 22.91 ± 6.67 14.32 
ethyl acetate 21.10 ± 0.24 230.19 ± 60.56 10.91 
stems:     
petroleum ether 1.11 ± 0.50 10.64 ± 0.97 9.59 
dichloromethane 3.05 ± 0.60 5.33 ± 1.59 1.75 
ethyl acetate 1.35 ± 0.30 34.37 ± 12.76 25.46 
ethanol 9.30 ± 0.46 112.79 ± 19.23 12.13 
Chloroquine 0.04 ± 0.006 125.56 ± 5.04 3139.00 
Quinine 0.13 ± 0.01 136.06 ± 4.06 1046.62 















lycorine,   a   compound   structurally   unrelated   to  both  
quinine and artemisinin, is consistently reported. This 
compound or structural derivatives thereof could inhibit 
parasite growth via the induction of apoptosis as already 
described for artemisinin derivatives (Jones et al., 2009). 
The authors recommend the inclusion of toxicity testing 
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Table 3. 1H and 13C NMR spectral assignments for isolated compound and 
lycorine (Likhitwitayawuid et al., 1993). 
 
Position 1Ha 1Hb 13Ca 13Cb 
1 4.28 (s) 4.27 (s) 71.66 70.21 
2 3.98 (s) 3.97 (s) 70.14 71.72 
3 5.35 (s) 5.37 (s)  118.48 
4   141.54 141.68 
4a 2.61 (d) 2.60 (d) 60.72 60.83 
6α 3.34 (d) 3.32 (d) 56.59 56.73 
β 4.05 (d) 4.02 (d)   
6a   129.56 129.75 
7 6.65 (s) 6.68 (s) 106.96 107.01 
8   145.16 145.20 
9   145.52 145.65 
10 6.80 (s) 6.81 (s) 105.01 105.06 
10a   129.60 129.57 
10b 2.48 (m) 2.50 (m) 42.0 40.18 
11αβ 2.44 (m) 2.44 (m) d28.10 28.13 
12α 2.20 (ddd) 2.19 (ddd) 5.24 53.31 
β 3.20 (dd) 3.19 (dd)   
OCH2O 5.92 (s) 5.94 (s) 100.51 100.57 
 
aChemical shifts are reported in ppm (δ) in DMSO-d6 for 1H and 13C. 
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